Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02536040 · ClinicalTrials.gov registry record · Phase 3
Stopping Cavities Study: Diammine Silver Fluoride
A Phase 3 study, sponsored by Advantage Dental Services.
- Completed
- Registry status
- Phase 3
- Development phase
- 66
- Enrollment target
NCT02536040: Completed Phase 3 study, sponsored by Advantage Dental Services.
NCT02536040 is a Phase 3 study that has completed, run by Advantage Dental Services. The registered enrollment target is 66 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02536040, a Phase 3 study, has completed, sponsored by Advantage Dental Services.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 66 participants
- Enrollment target
Study Summary
This study is being conducted to test whether the use of diammine silver fluoride (also called silver diamine fluoride) hardens the cavity sufficiently so that it arrests.
Primary Outcome
Proportion of treated teeth with active decay that were arrested by the treatment measured using the Nyvad criterion code 6 reflecting hardness of the lesion and color change
Interventions
- OTHER Water
- DRUG 38% diammine silver fluoride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2016-01 |
| Est. Completion | 2016-07 |
| Phase | Phase 3 |
What the finished NCT02536040 record still lists
NCT02536040 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which Water is the first listed.
NCT02536040 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02536040 about?
NCT02536040 is a clinical study titled "Stopping Cavities Study: Diammine Silver Fluoride". This study is being conducted to test whether the use of diammine silver fluoride (also called silver diamine fluoride) hardens the cavity sufficiently so that it arrests.
What is the current status of trial NCT02536040?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 66 participants. The study started on 2016-01. Estimated completion is 2016-07.
What interventions are being tested in trial NCT02536040?
The interventions under investigation include: Water (OTHER), 38% diammine silver fluoride (DRUG).
Who is sponsoring clinical trial NCT02536040?
This trial is sponsored by Advantage Dental Services, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02536040's enrollment target sits among peer trials
66 1797th of 2000 higher than 204 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia